Prodrug Pharmaceutical announced on August 5 that its wholly-owned subsidiary Zhejiang Projiayuan Pharmaceutical Co., Ltd. recently received the “Notice of Approval of the Marketing Application for Chemical Ingredient Application” for the active ingredient fluzelacide issued by the State Drug Administration.

Zhitongcaijing · 1d ago
Prodrug Pharmaceutical announced on August 5 that its wholly-owned subsidiary Zhejiang Projiayuan Pharmaceutical Co., Ltd. recently received the “Notice of Approval of the Marketing Application for Chemical Ingredient Application” for the active ingredient fluzelacide issued by the State Drug Administration.